Jaguar Health, Inc.
JAGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001585608
No open-market purchases or sales by Jaguar Health, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $15.9K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Jaguar Health, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- 0 vs. Q4 2023
- Shares held
- 5.83M
- +4.59M (+372.4%) vs. Q4 2023
- Total value
- $523.7K
- +$339.4K (+184.1%) vs. Q4 2023
- New holders
- 7
- 6 more added
- Sold out
- 7
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JAGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $15.9K |
| Q1 2026 | 11 | $94.2K |
| Q4 2025 | 11 | $61.4K |
| Q3 2025 | 9 | $222.9K |
| Q2 2025 | 8 | $35.2K |
| Q1 2025 | 8 | $24.6K |
| Q4 2024 | 12 | $283.4K |
| Q3 2024 | 13 | $387.1K |
| Q2 2024 | 12 | $367.0K |
| Q1 2024 | 20 | $523.7K |
| Q4 2023 | 20 | $184.4K |
| Q3 2023 | 14 | $153.2K |
| Q2 2023 | 16 | $231.3K |
| Q1 2023 | 16 | $229.0K |
| Q4 2022 | 30 | $502.9K |
| Q3 2022 | 28 | $873.0K |
| Q2 2022 | 27 | $1.74M |
| Q1 2022 | 33 | $3.94M |
| Q4 2021 | 28 | $4.75M |
| Q3 2021 | 30 | $12.8M |
| Q2 2021 | 36 | $31.9M |
| Q1 2021 | 45 | $13.7M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Jaguar Health, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 2 | $0 | 0.00% | −163,669−100.0% | Reduced |
| Royal Bank of Canada | 1 | $0 | 0.00% | −521−99.8% | Reduced |
| Wells Fargo & Company | 373 | $34 | 0.00% | +251+205.7% | Added |
| Group One Trading, L.P. | 737 | $66 | 0.00% | −9−1.2% | Reduced |
| Morgan Stanley | 1,679 | $151 | 0.00% | −44,707−96.4% | Reduced |
| ICA Group Wealth Management, LLC | 4,500 | $405 | 0.00% | +4,500 | New |
| Two Sigma Investments, LP | 26,026 | $2.34K | 0.00% | +26,026 | New |
| UBS Group AG | 43,506 | $3.92K | 0.00% | +6,351+17.1% | Added |
| Boothbay Fund Management, LLC | 49,773 | $4.47K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 59,328 | $5.34K | 0.00% | +59,328 | New |
| Focused Wealth Management, Inc | 74,077 | $6.66K | 0.00% | +74,077 | New |
| Csenge Advisory Group | 102,500 | $9.21K | 0.00% | +25,000+32.3% | Added |
| Geode Capital Management, LLC | 127,671 | $11.5K | 0.00% | −1,745−1.3% | Reduced |
| Susquehanna International Group, LLP | 157,303 | $14.1K | 0.00% | +157,303 | New |
| Vanguard Group Inc | 192,335 | $17.3K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 242,404 | $21.6K | 0.00% | +242,404 | New |
| XTX Topco Ltd | 450,634 | $40.5K | 0.01% | +450,634 | New |
| Jane Street Group, LLC | 798,485 | $71.8K | 0.00% | +781,925+4,721.8% | Added |
| Commonwealth Equity Services, LLC | 899,170 | $81.0K | 0.00% | +873,293+3,374.8% | Added |
| BlackRock Inc. | 2,595,782 | $233.4K | 0.00% | +2,544,627+4,974.3% | Added |
| FMR LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −193,330−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −100,684−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −62,255−100.0% | Sold out |
| Sterling Investment Advisors, Ltd. | 0 | $0 | 0.00% | −39,000−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −35,538−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,330−100.0% | Sold out |